Zura Bio Ltd SEC filings ZURA
Zura Bio Ltd has 446 filings in SEC EDGAR's recent list, going back to Apr 8, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Officer or director change
|
May 22, 2026 | May 20, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 19, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K/A | Amended current report | Feb 26, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Feb 26, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 23, 2026 | Feb 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 26, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Other events
|
Jan 2, 2026 | Dec 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 4, 2025 | Sep 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2025 | Aug 20, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 1, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2025 | May 27, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2025 | May 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2025 | May 20, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 17, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 24, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 23, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 25, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Oct 29, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 18, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 21, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Shareholder vote results, Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Other events
|
Aug 9, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2024 | Jul 24, 2024 |
| 8-K |
Current report
Other events
|
Jul 12, 2024 | Jul 12, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 2, 2024 | Mar 24, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2024 | May 29, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Apr 23, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 8, 2024 | Apr 8, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 28, 2024 | Mar 24, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Auditor change
|
Feb 23, 2024 | Mar 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 2, 2024 | Feb 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2024 | Jan 11, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 3, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 6, 2023 | Nov 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 4, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 25, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 3, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2023 | Sep 12, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 27, 2023 | Jul 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2023 | Jun 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 15, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Jun 6, 2023 | Jun 5, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 3, 2023 | Apr 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 27, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 14, 2023 | Apr 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2023 | Apr 7, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 7, 2023 | Apr 6, 2023 |
| 8-K | Current report | Apr 6, 2023 | Apr 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 28, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
|
Mar 24, 2023 | Mar 20, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 21, 2023 | Mar 20, 2023 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 15, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 10, 2023 | Mar 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2023 | Mar 2, 2023 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results
|
Jan 19, 2023 | Jan 12, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 12, 2022 | Dec 8, 2022 |
| 8-K |
Current report
Material agreement
|
Nov 15, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 17, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Restatement
|
Apr 8, 2022 | Apr 7, 2022 |
| 8-K |
Current report
Material agreement
|
Feb 2, 2022 | Jan 27, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2021 | Sep 24, 2021 |
| 8-K |
Current report
Material agreement
|
Aug 11, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jul 22, 2021 | Jul 16, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 19, 2021 | Jul 13, 2021 |
Showing 103 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- La Jolla, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1855644
- Former names
- JATT Acquisition Corp (until Mar 21, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.